Background
==========

Acute lung injury is a severe complication of hip fracture patients, especially in elderly ones \[[@b1-medscimonit-23-3367]\]. The overall in-hospital mortality of elderly patients is almost 5.0% \[[@b2-medscimonit-23-3367]\]. However, the detailed intracellular biochemical and molecular signals remain only partially understood. Long bed rest used to be regarded as the major risk of acute lung injury after fracture \[[@b3-medscimonit-23-3367]\]. Nevertheless, recent studies showed severe inflammatory responses may be responsible for the hip fracture-induced acute lung injury \[[@b4-medscimonit-23-3367],[@b5-medscimonit-23-3367]\].

There has been increasing interest in studying the role of endogenous danger signals in inflammatory damages. Recent studies showed that the mitochondria, consisting of formyl peptides and mitochondrial DNA (mtDNA), can activate neutrophils and induce inflammation \[[@b6-medscimonit-23-3367],[@b7-medscimonit-23-3367]\]. In addition, it was reported that the elevated mtDNA levels were related to the severity of systemic inflammatory response syndrome and secondary organ injuries in injured patients or animals \[[@b5-medscimonit-23-3367]--[@b8-medscimonit-23-3367]\]. Epigallocatechin gallate (EGCG) is a flavonoid belonging to the chemical class of falvan-3-ols esterified gallic acid present in green tea. Studies showed that EGCG possesses beneficial effects of this compound for organ protection due to its anti-inflammatory and anti-oxidant properties through enhancing mitochondrial function \[[@b9-medscimonit-23-3367]--[@b12-medscimonit-23-3367]\]. More importantly, Kasper et al. reported that EGCG has protective effects on inflammatory lung injury \[[@b13-medscimonit-23-3367]\].

Given the above evidence, in the present study we studied the protective effects of EGCG on hip fracture-induced acute lung injury and explored a possible mechanism by which EGCG exerts its effects through limiting mtDNA release.

Material and Methods
====================

Establishment of a hip fracture-induced lung injury model
---------------------------------------------------------

Thirty male Sprague-Dawley (SD) rats (250--300g) were obtained from the Animal Center of the West China Medical Center (Chengdu, China). All rats were randomly divided into 3 groups: control group (N=10), hip fracture group (N=10), and hip fracture + EGCG group (N=10). Rats in the hip fracture and hip fracture + EGCG groups were anesthetized by intraperitoneal injection of pentobarbital (50 mg/kg) and fentanyl (0.05 mg/kg), and then placed in a prone position on the base of a blunt guillotine ramming apparatus. Aimed at the proximal femur, the 500 *g* blunt guillotine was lifted to a 15 cm height followed by free-fall along the axis, causing a unilateral closed hip fracture \[[@b5-medscimonit-23-3367]\]. Rats in the hip fracture + EGCG group were peritoneally injected with EGCG (10 mg/Kg) at 10 min before the fracture was induced \[[@b13-medscimonit-23-3367]\]. Rats in the control group were received the same anesthesia only. After 24 h, all animals were sacrificed by cervical dislocation, followed by collection of blood and lung tissue samples. The study was performed in accordance with the guiding principles of the Bio-ethics Committee of West China Medical Center for the care and use of laboratory animals.

BALF collection and cytological study
-------------------------------------

For bronchoalveolar lavage fluid (BALF) collection, the left lung was lavaged 3 times with 2 ml of lavage buffer (PBS with 0.6 mm EDTA). The lavage was centrifuged at 1500 rpm for 10 min at 4°C, then the cell pellet at the bottom was re-suspended in 1 ml PBS. The total number of BALF cells was counted by a hemocytometer. Next, approximately 5×10^4^ cells were placed onto glass slides. Afterwards, the slides were air-dried and stained with Giemsa, and at least 300 cells were counted under a light microscope for differential cell analysis. The supernatants were frozen immediately and stored at --80°C for enzyme-linked immunosorbent assay (ELISA) assay.

Serum mtDNA measurement by real time-PCR (RT-PCR)
-------------------------------------------------

The blood was centrifuged at 3000 rpm for 15 min at 4°C to collect serum. The whole DNA was isolated from serum by using the DNeasy Blood and Tissue Kit (\#69504, Qiagen, Hilden, Germany). We used 100-μl serum samples to isolate the whole DNA. The procedures were performed carefully according to the manufacture's protocol. At the last step, 100 μl elution buffer were added to resolve DNA.

mtDNA levels were measured by SYBR-green dye-based RT-PCR assay using a PRISM 7300 sequence detection system. The primer sequences were human NADH dehydrogenase 1 gene (mtDNA): forward CGAGCAGTAGCCCAAACAAT, reverse TGTGATAAGGGTGGAGAGGTT; rat NADH dehydrogenase 1 gene (mtDNA): forward CGCCTGACCAATAGCCATAA, reverse ATTCGACGTTAAAGCCTGAGA. Concentration of serum mtDNA were converted to copy number via a DNA copy number calculator (*<http://cels.uri.edu/gsc/cndna.html>*; University of Rhode Island Genomics and Sequencing Center). All samples were measured with standards at the same time. Serum mtDNA levels are shown in copies per microliter of serum according to the following formula:
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Where c is the concentration of serum mtDNA (copies/μL); Q means quantity of DNA measured by RT-PCR; V~DNA~ means the total volume of serum DNA solution obtained from extraction, 100 μl in this study; V~PCR~ means the volume of serum DNA solution for RT-PCR, 1 μl in this study; V~ext~ means the volume of serum used for extraction, 100 μl in this study \[[@b14-medscimonit-23-3367]\].

Pathological analysis of the lung tissue
----------------------------------------

Lung tissue was collected in all groups and stored in formalin for 24 h. Part of the lung tissue was embedded in paraffin. Tissue sections (5 μm) were obtained and stained with hematoxylin and eosin (HE). Five slices were randomly selected from each rat and 5 fields of each slices were examined. Using the lung injury scoring system, the average score was calculated \[[@b15-medscimonit-23-3367]\].

Lung wet/dry ratio was used as an index of pulmonary edema. The same portion of lung tissue (right middle lobe) was weighed to measure the wet weight and then placed in an 80°C dry oven for 2 days to get the dry weight.

Measurement of inflammatory cytokines
-------------------------------------

BALF inflammatory cytokines (TNF-α and IL-6) were measured by ELISA system (Elabscience, China).

Statistical analysis
--------------------

All descriptive data are presented as mean ±SD. Statistical significance was evaluated by the *t* test and one-way ANOVA followed by the Bonferroni post hoc test. Differences were considered significant at the level of *p*\<0.05.

Results
=======

EGCG attenuates hip fracture-induced elevated serum mtDNA level
---------------------------------------------------------------

[Figure 1](#f1-medscimonit-23-3367){ref-type="fig"} shows the significant increase of mtDNA level in the hip fracture group (*p*\<0.05). More importantly, treatment with EGCG resulted in a significant decrease in mtDNA (*p*\<0.05). The data demonstrate that EGCG can effectively limit the release of mtDNA.

EGCG attenuates hip fracture-induced acute lung injury
------------------------------------------------------

HE staining images of lung tissue are shown in [Figure 2A--C](#f2-medscimonit-23-3367){ref-type="fig"}. Normal pulmonary histology was found in the control group, but the hip fracture group had excessive infiltration of inflammatory cells and thickening of the alveolar wall. With the administration of EGCG, HE staining showed better lung condition compared to the hip fracture group. The lung injury scores in the hip fracture group were much higher than in the control and hip fracture + EGCG groups ([Figure 2D](#f2-medscimonit-23-3367){ref-type="fig"}, *p*\<0.05). Lung wet/dry ratio ([Figure 2E](#f2-medscimonit-23-3367){ref-type="fig"}) also had a higher ratio in the hip fracture group than in the control and hip fracture + EGCG groups (*p*\<0.05).

EGCG attenuates hip fracture-induced inflammatory cells infiltration in the BALF
--------------------------------------------------------------------------------

We further detected inflammatory cells infiltration in the lung through cytological study of BALF. As shown in [Figure 3](#f3-medscimonit-23-3367){ref-type="fig"}, hip fracture resulted in significant increases in total cell count, monocyte/macrophage numbers, and neutrophile numbers (*p*\<0.05). As expected, rats with EGCG pre-treatment all showed decreased number of total cells, monocyte/macrophage numbers, and neutrophile numbers (*p*\<0.05).

EGCG attenuates hip fracture-induced inflammatory cytokines production in the BALF
----------------------------------------------------------------------------------

Significant increases of inflammatory cytokines (TNF-α and IL-6) were shown in the hip fracture group (*p*\<0.05, [Figure 4](#f4-medscimonit-23-3367){ref-type="fig"}). Pre-treatment with EGCG showed significantly inhibited effects on the production of inflammatory cytokines (*p*\<0.05).

Discussion
==========

In the present study, by studying the HE staining of lung tissue, cytological study, and BALF inflammatory cytokines analysis, we found protective effects of EGCG on hip fracture-induced acute lung injury. We also found that EGCG limited the release of mtDNA. Given the pro-inflammatory property of mtDNA, our results suggest that EGCG can attenuate hip fracture-induced acute lung injury through limiting the release of mtDNA.

It is well known that inflammatory responses are responsible for the development of acute lung injury after trauma \[[@b16-medscimonit-23-3367],[@b17-medscimonit-23-3367]\]. In our study, we established the hip fracture-induced acute lung injury rat model without bacteria or endotoxin challenges. In the hip fracture group, significant lung injury and inflammatory responses were identified. Consistent with other studies, our results suggest that hip fracture can result in non-infectious inflammatory responses leading to acute lung injury \[[@b18-medscimonit-23-3367]\]. Additionally, some studies reported mitochondrial oxidative damage in hip fracture-induced systemic inflammatory responses \[[@b19-medscimonit-23-3367]\]. It is reported that mtDNA can be released after cells or mitochondria are insulted \[[@b20-medscimonit-23-3367]\]. Further studies demonstrated that mtDNA-mediated activation of neutrophils and formation of neutrophil extracellular traps, as well as activation of the inflammatory signaling pathway, may aggravate the inflammatory responses in several pathological conditions \[[@b5-medscimonit-23-3367],[@b21-medscimonit-23-3367]\]. In the present study, we also confirmed elevated mtDNA levels after hip fracture. In agreement with other studies, we showed that elevated mtDNA levels play a key role in the development of hip fracture-induced acute lung injury through activating the Toll-like receptor-9 signaling pathway \[[@b5-medscimonit-23-3367],[@b6-medscimonit-23-3367],[@b22-medscimonit-23-3367],[@b23-medscimonit-23-3367]\].

Interestingly, the administration of EGCG, the main constituent of green tea, remarkably attenuated lung injury and decreased inflammatory responses in lung tissue of subjects with hip fracture. Surprisingly, as an initiator of inflammatory responses, mtDNA level was also reduced by EGCG treatment. It is well known that EGCG has anti-inflammatory effects \[[@b24-medscimonit-23-3367]\], but the detailed mechanism is still unclear. Recently, increasing numbers of studies have shown the anti-oxidative effects of EGCG, which inhibited endothelial dysfunction and formation of reactive oxygen species \[[@b9-medscimonit-23-3367],[@b15-medscimonit-23-3367],[@b25-medscimonit-23-3367]\]. Therefore, our data suggest that the anti-oxidative effects of EGCG may be a mechanism by which it exerts anti-inflammatory effects.

Although we had some interesting results, some limitations need to be noted. First, in the present study, lack of a specific mtDNA antagonist made the interpretation of our data less clear. However, as an initiator of inflammatory responses, the reduction of mtDNA level had its own effects on the decreased inflammatory responses. Second, we did not further explore how EGCG inhibits the release of mtDNA. Finally, further studies are needed to prove the clinical preventive effects of EGCG on hip-fracture-induced lung injury, as well as to study the detailed mechanism of the protective effects of EGCG on hip fracture-induced acute lung injury.

Conclusions
===========

We found that EGCG had protective effects on hip fracture-induced acute lung injury and that EGCG may have exerted its protective effects through limiting the release of mtDNA. Our results provide a novel pharmacological agent to attenuate hip fracture-induced acute lung injury and suggest a theory that might help to better understand the anti-inflammatory property of EGCG, providing deeper insights into the possible pharmacological utilization of EGCG.
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![EGCG attenuates hip fracture-induced elevated serum mtDNA level. Significantly increased mtDNA level in the hip fracture group (*p*\<0.05). EGCG treatment significantly decreased mtDNA (*p*\<0.05). *\* p*\<0.05 *vs.* control group, ^\#^ *p*\<0.05 *vs.* the hip fracture group, N=10.](medscimonit-23-3367-g001){#f1-medscimonit-23-3367}

![EGCG attenuates hip fracture-induced acute lung injury. (**A--C**) HE staining images of 3 groups are shown. (**D**) The lung injury scores in the hip fracture group were much higher than in the control and hip fracture + EGCG groups. (**E**) The higher ratio in the hip fracture group than in the control and hip fracture + EGCG groups. *\* p*\<0.05 *vs.* control group, ^\#^ *p*\<0.05 *vs.* the hip fracture group, N=10.](medscimonit-23-3367-g002){#f2-medscimonit-23-3367}

![EGCG attenuates hip fracture-induced inflammatory cells infiltration in the BALF. Rats with EGCG pre-treatment all showed decreased numbers of total cells, monocyte/macrophage number, and neutrophile number compared with the hip fracture group. *\* p*\<0.05 *vs.* control group, ^\#^ *p*\<0.05 *vs.* hip fracture group, N=10.](medscimonit-23-3367-g003){#f3-medscimonit-23-3367}

![EGCG attenuates hip fracture-induced inflammatory cytokines production in the BALF. Significant increases of inflammatory cytokines (TNF-α and IL-6) are shown in the hip fracture group, and pre-treatment with EGCG significantly inhibited the production of inflammatory cytokines (*p*\<0.05). *\* p*\<0.05 *vs.* control group, ^\#^ *p*\<0.05 *vs.* the hip fracture group, N=10.](medscimonit-23-3367-g004){#f4-medscimonit-23-3367}
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